BIODESIX, INC. (BDSX) Operating margin 2019–2025
BIODESIX, INC. (BDSX) operating margin by fiscal year — reported operating income divided by reported revenue.
-31.5%FY2025 · since FY2019: -108.9% → -31.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -31.5% | +16.9 pp |
| FY2024 | -48.4% | +35.9 pp |
| FY2023 | -84.2% | +48.2 pp |
| FY2022 | -132.4% | -57.3 pp |
| FY2021 | -75.1% | -24.8 pp |
| FY2020 | -50.3% | +58.6 pp |
| FY2019 | -108.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BDSX financial trends
BDSX RevenueBDSX Net incomeBDSX Net marginBDSX Gross profitBDSX Gross marginBDSX Operating incomeBDSX Operating cash flowBDSX Free cash flowBDSX Capital expendituresBDSX Return on equityBDSX Stock buybacksBDSX Dividends paidBDSX Total assetsBDSX Total liabilitiesBDSX Shareholders’ equityBDSX overview →